Clear Search
·
2 Min Read

Why you should act now on your Sunshine Act data

This fall, patients will be able to see what kinds of financial interactions you may have had with manufacturers of drugs and medical devices. Physicians have less than 30 days to review this information, reported by industry organizations, and make sure it’s accurate.

series
Leadership
Leadership Viewpoints
·
4 Min Read

How to dispute incorrect financial data before it goes public

Physicians can review reports about their financial interactions with manufacturers of drugs and medical devices now through Aug. 27 under the Physician Payments Sunshine Act (also known as the Open Payments program).

Medicare & Medicaid
·
2 Min Read

Physicians should know about their personal data, AMA tells CMS

Personally identified data about physicians not publicly available soon could be shared with government agencies, law enforcement and Medicare contractors without physicians’ knowledge, under a new “system of records” announced by the Centers for Medicare & Medicaid Services (CMS).

Medicare & Medicaid
·
3 Min Read

Sunshine Act proposal threatens doctors' due process for disputes

A newly proposed dispute resolution process for inaccurate Physician Payments Sunshine Act data would deny physicians their due process rights, the AMA told the Centers for Medicare & Medicaid Services in a comment letter last week that calls for fairness and urges the agency to modify the deadline for publication of physicians’ payment data.

Medicare & Medicaid
·
3 Min Read

Extend review timeline for Sunshine Act, AMA tells CMS

Physicians won’t have enough time to review and challenge false or inaccurate data about financial interactions they have had with drug and medical device companies as a result of delays by the Centers for Medicare & Medicaid Services in implementing the Physician Payments Sunshine Act, the AMA told the agency.

Medicare & Medicaid
·
3 Min Read

AMA's leadership in medical ethics guides teachers and learners in medicine

The AMA has three ethical opinions that emphasize the need for independence, transparency and accountability in continuing medical education (CME).

Ethics